Halozyme Therapeutics, Inc. · NASDAQ:HALO
Snyder Mark Howard exercised options for 5,034 Halozyme Therapeutics, Inc. shares (Form 4)
Traded Jun 12, 2026 · Filed Jun 15, 2026
On Jun 12, 2026, Snyder Mark Howard (SVP, CHIEF LEGAL OFFICER) exercised options for 5,034 Halozyme Therapeutics, Inc. shares, leaving 49,929 shares. Filed Jun 15, 2026 (Form 4).
- Options exercised
- 5,034 shares
- Holding after
- 49,929 shares
- Trading plan
- No
- Role
- SVP, CHIEF LEGAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Common Stock | Option exercise | 5,034 | 52,644 | Direct | |
| Jun 12, 2026 | Common Stock | Shares withheld for tax | 2,715 | US$69.50 | 49,929 | Direct |